Otros idiomas Cisen Pharmaceutical Co., Ltd.

Acciones

603367

CNE100002VG4

Precio de cierre Shanghai S.E. Otros sitios de cotización 00:00:00 21/06/2024			Varia. Cinco días.	Varia. 1 de enero.
14,62 ^CNY	+1,67 %		-1,42 %	-0,14 %

22/04	Cisen Pharmaceutical Co. informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
2023	Cisen Pharmaceutical desecha el plan de escisión de la unidad	CI

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

Han Yanzhen signed share transfer agreement to acquire 10.03% stake in Cisen Pharmaceutical Co., Ltd. from Beihai Chenxin Venture Capital Co., Ltd. for approximately CNY 680 million.	15/05
Cisen Pharmaceutical Names Chief Financial Officer	23/04
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	22/04
Cisen Pharmaceutical Scraps Unit Spin-Off Plan	01/12
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23
Cisen Pharmaceutical Co., Ltd.(XSSC:603367) added to S&P Global BMI Index	18/09/23
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24/08/23
Cisen Pharmaceutical to Spin Off Unit for Shenzhen Float	09/06/23
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/04/23
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23
Cisen Pharmaceutical Secures Regulatory Approval for Methylcobalamin Tablets	22/11/22
Cisen Pharmaceutical Gets Regulatory Approval for Registration of Two Drugs	17/11/22
Cisen Pharma Gets Regulatory Nod For Flu Drug's China Clinical Trial	09/11/22
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	17/10/22
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22/08/22
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	26/04/22
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	25/03/22
Shijiazhuang No.4 Pharmaceutical Co., Ltd. completed the acquisition of 6.1% stake in Cisen Pharmaceutical Co., Ltd. from Wu Hengke.	31/12/21
Cisen Pharmaceutical Co., Ltd.(XSSC:603367) dropped from S&P Global BMI Index	20/12/21
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	26/10/21

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Cisen Pharmaceutical Co., Ltd.

Acciones

603367

CNE100002VG4

Otros idiomas

Filtros